Jean Michel Maixent

Prof. Jean Michel Maixent

School of Sciences, University of Poitiers, Poitiers, France
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MGMélanie Gaubert
Mélanie Gaubert
TBThomas Bardin
Thomas Bardin
ACAlain Cohen-Solal
Alain Cohen-Solal
FDFrançois Diévart
François Diévart
JFJean-Pierre Fauvel
Jean-Pierre Fauvel
PFPaganelli Franck
Paganelli Franck
Since the publication of the Framingham Heart Study, which suggested that uric acid should no longer be associated with coronary heart disease after additional adjustment for cardiovascular disease risk factors, the number of publications challenging this statement has dramatically increased. The aim of this paper was to review and discuss the most recent studies addressing the possible relation between sustained elevated serum uric acid levels and the onset or worsening of cardiovascular and renal diseases. Original studies involving American teenagers clearly showed that serum uric acid levels were directly correlated with systolic and diastolic pressures, which has been confirmed in adult cohorts revealing a 2.21-fold increased risk of hypertension. Several studies involving patients with coronary artery disease support a role for serum uric acid level as a marker and/or predictor for future cardiovascular mortality and long-term adverse events in patients with coronary artery disease. Retrospective analyses have shown an inverse relationship between serum uric acid levels and renal function, and even a mild hyperuricemia has been shown to be associated with chronic kidney disease in patients with type 2 diabetes. Interventional studies, although of small size, showed that uric acid (UA)-lowering therapies induced a reduction of blood pressure in teenagers and a protective effect on renal function. Taken together, these studies support a role for high serum uric acid levels (>6 mg/dL or 60 mg/L) in hypertension-associated morbidities and should bring awareness to physicians with regards to patients with chronic hyperuricemia.

Verified
Journal Article
Open access
PDF file
MGMARINE GAUDRY
MARINE GAUDRY
DVDonato Vairo
Donato Vairo
MMMarion Marlinge
Marion Marlinge
MGMelanie Gaubert
Melanie Gaubert
CGClaire Guiol
Claire Guiol
PFPaganelli Franck
Paganelli Franck
Adenosine is an endogenous nucleoside which strongly impacts the cardiovascular system. Adenosine is released mostly by endothelial cells and myocytes during ischemia or hypoxia and greatly regulates the cardiovascular system via four specific G-protein-coupled receptors named A1R, A2AR, A2BR, and A3R. Among them, A2 subtypes are strongly expressed in coronary tissues, and their activation increases coronary blood flow via the production of cAMP in smooth muscle cells. A2A receptor modulators are an opportunity for intense research by the pharmaceutical industry to develop new cardiovascular therapies. Most innovative therapies are mediated by the modulation of adenosine release and/or the activation of the A2A receptor subtypes. This review aims to focus on the specific exploration of the adenosine plasma level and its relationship with the A2A receptor, which seems a promising biomarker for a diagnostic and/or a therapeutic tool for the screening and management of coronary artery disease. Finally, a recent class of selective adenosine receptor ligands has emerged, and A2A receptor agonists/antagonists are useful tools to improve the management of patients suffering from coronary artery disease.

17 August 2015 in Molecules
Verified
Journal Article
Open access
PDF file
LBLaura Braud
Laura Braud
LPLudovic Peyre
Ludovic Peyre
GSGeorges De Sousa
Georges De Sousa
Martine ArmandMartine Armand
Martine Armand
RRRoger Rahmani
Roger Rahmani
JMJean Michel Maixent
Jean Michel Maixent
Tea is an interesting source of antioxidants capable of counteracting the oxidative stress implicated in liver diseases. We investigated the impact of antioxidant molecules provided by a mixture of teas’ leaves (green, oolong, pu-erh) after different infusion durations in the prevention of oxidative stress in isolated rat hepatocytes, by comparison with pure epigallocatechin-3-gallate (EGCG), the main representative of tea catechins. Dried aqueous tea extracts (ATE) obtained after 5, 15 and 30 min infusion time were characterized for total polyphenols (gallic acid equivalent), catechins, gallic acid and caffeine (HPLC-DAD/ESI-MS) contents, and for scavenging ability against 2,2-diphenyl-1-picrylhydrazyl free radical. Hepatoprotection was evaluated through hepatocyte viability tests using tert-butyl hydroperoxide as a stress inducer, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, neutral red uptake, real-time cellular impedance) and mitochondrial function tests. We showed that a 5-min incubation time is sufficient for an optimal bioaccessibility of tea compounds with the highest antioxidative ability, which decreases for longer durations. A 4-h pretreatment of cells with ATE significantly prevented cell death by regulating reactive oxygen species production and maintaining mitochondrial integrity. Pure EGCG, at doses similar in ATE (5–12 µM), was inefficient, suggesting a plausible synergy of several water-soluble tea compounds to explain the ATE beneficial effects.

1 January 2015 in Journal of Complementary Medicine Research
Verified
Journal Article
Open access
CFC Francois
C Francois
MFM Fares
M Fares
CBC Baiocchi
C Baiocchi
JMJean Michel Maixent
Jean Michel Maixent
The increased consumption of traditional medicinal plants has been driven by the notion that herbal products are safe and efficient. The purpose of this study was to evaluate the safety and the protective effect of a hydro alcoholic extract of Desmodium adscendens (DA) on liver (HEPG2) and kidney (LLC-PK1) cells. A hydro alcoholic extract of DA was used. HEPG2 or LLC-PK1 cells were treated with different does of DA, and viability test (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium [MTS]), cytotoxicity assay lactate dehydrogenase (LDH release) and study of the cell morphology were used in order to determine effects of DA on these two cells. A viability test (MTS), a cytotoxicity assay LDH release and a study of the cell morphology revealed that pretreatment with 1 mg/ml or 10 mg/ml DA did not alter viability or LDH release in HEPG2 or LLC-PK1 cells. However, DA at the dose of 100 mg/ml significantly decreased cell viability, by about 40% (P < 0.05). Further, MTS studies revealed that DA 1 mg/ml or 10 mg/ml protected LLC-PK1 cells against a glucose-induced oxidative stress of 24 h (P < 0.05). Hence, the lowest concentrations of DA (1 mg/ml and 10 mg/ml) were safe for HEPG2 and LLC-PK1 and protective against an oxidative stress in LLC-PK1 cells. These data suggest that DA extracts used as a traditional herbal as food health supplements should be used at the lowest dosage.

30 April 2019 in Cellular and Molecular Biology
Verified
Journal Article
Closed access
PDF file
JMJean Michel Maixent
Jean Michel Maixent
JZJean Marc Zeil
Jean Marc Zeil
Tea and herbal infusions have been known for millennia for their health benefits. However for plants and active ingredients (of mineral and animal origin), it is necessary to consume very large quantities to achieve what is called the health claim dose, i.e., the dose for which the effect on health claim is established. Camellia sinensis leaves is traditionally used as plant infusion. This article aims to review the innovation afforded by the ABC (Bio Concentrate Assets®) patent. The ABC patent has developed an exclusive method of enriching organic tea leaves with organic herbal dry plant extracts using organic acacia gum. This method allows the coupling of concentrated dry extracts from medicinal plants on the Camellia sinensis leave extracts using acacia gum (arabic gum) and to reach to low enough health claim doses thanks to a higher concentration of active ingredients (tested until 10 ingredients). An example of ABC application is provided in a brief overview of manufacturing process for the "Gingo® tea” preparation. The main advantages of the ABC patent application are discussed. In conclusion, the ABC process offers a real breakthrough in the market of teas and herbal teas for health and wellness.

1 January 2020 in Cellular and Molecular Biology
Verified
Journal Article
Open access
PDF file
JMJean Michel Maixent
Jean Michel Maixent
OPOlivier Pons
Olivier Pons
SSSouad R. Sennoune
Souad R. Sennoune
SSStéphane Sadrin
Stéphane Sadrin
The objective of this communication is to present and analyze the recent results from the LAPIBSS study in order to improve future clinical trials on the effects of Lactobacillus strains in the treatment of irritable bowel syndrome (IBS). Using a tightly-controlled clinical trial protocol with the highest Jadad score of 5/5, the current trial aimed to demonstrate the efficacy of a 2-strain mixture of: Lactobacillus acidophilus (L. acidophilus) to improve IBS symptoms. Eighty patients diagnosed with IBS according to Rome III criteria were recruited to a multicentric, double-blind, in parallel groups, placebo-controlled, randomized clinical trial. Patients were provided with a daily dose of two capsules containing either two probiotic strains (5 x 10(9) cfu/capsule) or placebo for 8 weeks. The primary endpoint was abdominal pain score assessed with a 100-mm visual analogue scale (VAS). Secondary endpoints included scores of bloating, flatus and rumbling assessed with a 100-mm VAS, a composite score that consisted of the sum of the 4 VAS scores, and the stool frequency and consistency assessed with the Bristol Stool Form Scale. Our study has failed to demonstrate a significant improvement of the primary endpoint of abdominal pain. Significant differences between groups were observed for flatus score at week 4 (P=0.04) and week 8 (P=0.03) and for composite score at week 8 (P=0.04). The consumption of the 2-strain mixture of L. acidophilus over 8 weeks is safe, significantly decreases flatus and composite scores. The significant effect on flatus could result from the species-specific homofer-mentative properties of L. acidophilus strains. The negative results on abdominal pain and the gained experience are discussed for the future clinical trials in IBS.